Skip to content

BOVISEL: what changed

BE 0826.254.314NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€2,612
2024 · €4,245-€1,632
Equity
€62,755
2024 · €60,143+€2,612
Cash
€6,190
2024 · €5,876+€314
Balance sheet total
€73,406
2024 · €79,693-€6,287

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€3,068

    down €3,068 (-95.3%), from €3,218 to €150

    of which Trade receivables: -€3,199

  • Tangible fixed assets -€2,981

    down €2,981 (-4.3%), from €68,569 to €65,588

Equity and liabilities
  • Debts after one year -€8,189

    down €8,189 (-100%), from €8,189 to €0

  • Reserves +€2,612

    up €2,612 (+5.0%), from €52,143 to €54,755

  • Tax, wage and social debts -€837

    down €837 (-31.4%), from €2,670 to €1,832

Income statement
  • Gross operating margin -€2,332

    down €2,332 (-22.9%), from €10,168 to €7,836

  • Taxes -€787

    down €787 (-37.0%), from €2,124 to €1,338

  • Financial income -€165

    down €165 (-85.3%), from €193 to €28

  • Financial charges -€113

    down €113 (-22.2%), from €508 to €395

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €4,245
Gross operating margin -€2,332
Other operating charges -€34
Financial income -€165
Financial charges +€113
Taxes +€787
Result 2025 €2,612
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€8,390
Investment €0
Financing -€8,075
Cash 2024 €5,876
Net result for the year +€2,612
Depreciation +€2,981
Receivables within one year +€3,068
Deferred charges and accrued income +€552
Trade debts -€11
Tax, wage and social debts -€837
Accrued charges and deferred income +€24
Debts after one year -€8,189
Current portion of long-term debt +€113
Cash 2025 €6,190
brings cash intakes cash out
Every line side by side 37 lines
Line Code 2024 2025 Change %
Total assets 20/58 €79,693 €73,406 -€6,287 -7.9%
Fixed assets 21/28 €68,569 €65,588 -€2,981 -4.3%
Tangible fixed assets 22/27 €68,569 €65,588 -€2,981 -4.3%
Other tangible fixed assets 26 €68,569 €65,588 -€2,981 -4.3%
Current assets 29/58 €11,124 €7,818 -€3,306 -29.7%
Amounts receivable within one year 40/41 €3,218 €150 -€3,068 -95.3%
Trade receivables 40 €3,199 €0 -€3,199 -100%
Other amounts receivable 41 €19 €150 +€131 +700%
Cash at bank and in hand 54/58 €5,876 €6,190 +€314 +5.3%
Deferred charges and accrued income 490/1 €2,031 €1,479 -€552 -27.2%
Total equity and liabilities 10/49 €79,693 €73,406 -€6,287 -7.9%
Equity 10/15 €60,143 €62,755 +€2,612 +4.3%
Contributions 10/11 €8,000 €8,000 = 0.0%
Reserves 13 €52,143 €54,755 +€2,612 +5.0%
Distributable reserves 133 €52,143 €54,755 +€2,612 +5.0%
Amounts payable 17/49 €19,550 €10,651 -€8,899 -45.5%
Amounts payable after more than one year 17 €8,189 €0 -€8,189 -100%
Financial debts 170/4 €8,189 €0 -€8,189 -100%
Amounts payable within one year 42/48 €10,858 €10,123 -€735 -6.8%
Current portion of amounts payable after more than one year 42 €8,075 €8,189 +€113 +1.4%
Trade debts 44 €113 €102 -€11 -9.8%
Suppliers 440/4 €113 €102 -€11 -9.8%
Taxes, remuneration and social security 45 €2,670 €1,832 -€837 -31.4%
Taxes 450/3 €2,670 €1,832 -€837 -31.4%
Accrued charges and deferred income 492/3 €503 €528 +€24 +4.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,981 €2,981 = 0.0%
Other operating charges 640/8 €503 €538 +€34 +6.8%
Gross operating margin 9900 €10,168 €7,836 -€2,332 -22.9%
Operating profit (loss) 9901 €6,683 €4,317 -€2,367 -35.4%
Financial income 75/76B €193 €28 -€165 -85.3%
Recurring financial income 75 €193 €28 -€165 -85.3%
Financial charges 65/66B €508 €395 -€113 -22.2%
Recurring financial charges 65 €508 €395 -€113 -22.2%
Profit (loss) for the period before taxes 9903 €6,369 €3,950 -€2,419 -38.0%
Income taxes 67/77 €2,124 €1,338 -€787 -37.0%
Profit (loss) for the period 9904 €4,245 €2,612 -€1,632 -38.5%
Profit (loss) for the period to be appropriated 9905 €4,245 €2,612 -€1,632 -38.5%

Value

latest balance sheet 30-06-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€47,085 to €53,368

Midpoint €49,703 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €62,755
Capitalised earnings €31,414 to €43,980
Indication €47,085 to €53,368

Adjusted equity

balance sheet 30-06-2025
Equity (10/15)
€62,755
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€62,755

Capitalised earnings

net result for the year (9904)
2025
€2,612
2024
€4,245
2023
€6,337
2022
€6,118
2021
€7,968
Average result
€4,398
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€31,414 / €36,650 / €43,980

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 11 November 2026 via checked.be.